Evidence map›Paper›PMID 38043732›Full record

ArticleJournal of molecular biology2024

Regulatory Intersection of Two-component System and Ser/Thr Protein Kinase Signaling in Mycobacterium tuberculosis.

Andrew Frando, Vishant Boradia, Christoph Grundner

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrew FrandoSeattle Children's Research Institute, Seattle, WA, United States.
Vishant BoradiaSeattle Children's Research Institute, Seattle, WA, United States.
Christoph GrundnerSeattle Children's Research Institute, Seattle, WA, United States; Department of Pediatrics, University of Washington, Seattle, WA, United States; Department of Global Health, United States. Electronic address: christoph.grundner@seattlechildrens.org.
Center for Infectious Disease Research · US

Funding

Seattle Tuberculosis Research Advancement CenterP30AI168034 · NIAID · UNIVERSITY OF WASHINGTON · PI Rhea N Coler, CHETAN SESHADRI · 2022 to 2026
$6.3M
Dual Targeting of Mtb Resistance MechanismsR01AI158159 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI GRUNDNER, CHRISTOPH · 2020 to 2024
$4.0M
INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIST32AI055396 · NIAID · UNIVERSITY OF WASHINGTON · PI FANG, FERRIC C · 2003 to 2019
$2.8M
Functional exploration of a deep Mycobacterium tuberculosis phosphoproteomeR01AI170914 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Christoph Grundner · 2023 to 2026
$2.4M
Functional phosphosignaling in Mtb infectionR21AI153766 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI GRUNDNER, CHRISTOPH · 2020 to 2021
$491k
NIAID NIH HHS P30 AI168034NIAID NIH HHS R01 AI158159NIAID NIH HHS R01 AI170914NIAID NIH HHS R21 AI153766NIAID NIH HHS T32 AI055396
6 · The paper itself

Abstract

Phosphosignaling in bacteria is mediated by two distinct systems, the two-component systems (TCSs) and the protein Ser/Thr/Tyr, or O-phosphorylation systems. These two arms of phosphosignaling are currently thought to be largely independent from one another. We mined a deep Mycobacterium tuberculosis (Mtb) phosphoproteome and identified over 170 O-phosphorylation sites on histidine kinases and response regulators of TCSs, suggesting that the two signaling pathways extensively intersect. Several TCSs were phosphorylated on multiple sites, and many by multiple Ser/Thr protein kinases, suggesting convergent and cooperative regulatory interactions. To test in which way these O-phosphorylation sites affect TCS activity, we reconstituted the NarSL phosphorelay in vitro. The Ser/Thr protein kinase PknL phosphorylated the histidine kinase NarS and activated its autophosphorylating activity. A phosphoablative mutation at the PknL phosphorylation site Thr380 resulted in low autophosphorylating activity, whereas a phosphomimetic mutation strongly activated autophosphorylation. The phosphomimetic mutation also resulted in more efficient phosphotransfer from NarS to the response regulator NarL and suppression of gene expression. These data show control of NarSL signaling by STPKs through a phosphoswitch and point to extensive, functional crosstalk between TCSs and O-phosphorylation.

Indexed as

Bacterial ProteinsMycobacterium tuberculosisProtein Serine-Threonine KinasesPhosphorylationBacterial ProteinsProtein Serine-Threonine KinasesMycobacterium tuberculosisphosphosignalingSer/Thr kinasetwo-component system

Identifiers

PMID38043732
PMCPMC11251531
OpenAlexW4389247542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.